Inactive

Helios Technologies Announces Retirement of Chief Financial Officer Tricia L. Fulton and Names Sean P. Bagan as Successor

Retrieved on: 
Tuesday, July 18, 2023
Other Manufacturing, Electronic Design Automation, Automotive, Engineering, Technology, Automotive Manufacturing, General Automotive, Manufacturing, Treasury, LLP, Shared services, Fulton, International, Polaris Inc., University of Cambridge, Cambridge University Press & Assessment, Arthur Andersen, Inactive, Multimedia, Certified Public Accountant, Business school, Retirement, CFO, Knowledge, Growth, Financial management, NYSE, Management, Polaris, Helios, Accounting

“Before I joined Helios, Tricia navigated the Company back from a challenging time in 2020.

Key Points: 
  • “Before I joined Helios, Tricia navigated the Company back from a challenging time in 2020.
  • Her knowledge and expertise of our businesses combined with her steadfast leadership and contributions have been invaluable to Helios.
  • Bagan joins Helios after spending 23 years at Polaris Inc., a global leader in powersports and off-road innovation.
  • With extensive financial management leadership experience, Bagan brings more than 20 years of international business, strategic financial operations, and leadership experience.

Equus Forms Morgan E&P, LLC as New Oil and Gas Subsidiary

Retrieved on: 
Tuesday, May 16, 2023
Permian, San Juan Basin, Senior, Hydrogen, Crescent Point Energy, Equinor, Inactive, Ute, Acquisition, Business Growth Fund, Certified Public Accountant, Investment, AAA, CPA, Chartered Financial Analyst, Morgan, EQS, NYSE, Family, CCUS, Oil, Engineering, EBITDA

HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Company”) announced the formation of a new wholly-owned subsidiary, Morgan E&P, LLC (“Morgan”).

Key Points: 
  • HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Company”) announced the formation of a new wholly-owned subsidiary, Morgan E&P, LLC (“Morgan”).
  • Morgan will focus on the acquisition, development and operation of oil and gas assets with a particular emphasis generally in the Bakken area of North Dakota (Williston Basin).
  • John Hardy, Morgan’s CEO, has brought on three seasoned oil and gas executives with over 70 years of combined experience.
  • Aside from upstream operations, he has been responsible for strategy development, field development planning, project development and execution for midstream, gas utility, LNG, hydrogen, CCUS projects and operations for over 1,000 miles of oil and gas transmission pipelines, sour gas treating and energy infrastructure.

Ascent Industries Appoints Bill Steckel as Chief Financial Officer

Retrieved on: 
Monday, April 17, 2023
Chemicals, Plastics, Other Manufacturing, Manufacturing, Steel, Treasury, TYO, GLDD, Internet of things, Inactive, ERP, Certified Public Accountant, Business administration, EBITDA, Acquisition, Pleasure, CFO, Growth, Master of Business Administration, Management, Western Illinois University, Ascent

Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), an industrials company focused on the production and distribution of industrial tubular products and specialty chemicals, today announced the appointment of Bill Steckel as chief financial officer, effective today.

Key Points: 
  • Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), an industrials company focused on the production and distribution of industrial tubular products and specialty chemicals, today announced the appointment of Bill Steckel as chief financial officer, effective today.
  • Mr. Steckel brings to Ascent more than two decades of extensive experience in operational finance, financial planning and analysis and treasury across a wide range of industries, as well as expertise in capital markets and M&A.
  • Prior to joining Ascent, he spent over five years in multiple CFO assignments for manufacturing, distribution and technology companies.
  • “It is a pleasure to welcome such a seasoned executive like Bill to the Ascent team,” said Chris Hutter, president and CEO of Ascent.

AINS, LLC Announces Patrick Kannan as Chief Financial Officer

Retrieved on: 
Monday, December 5, 2022
American Institute, Culture, Software, Certified Public Accountant, Lockheed Martin, Raytheon Technologies, Radford University, Boeing, Business administration, CFO, Software as a service, Thoma Bravo, BAE Systems, Rolls-Royce, AICPA, FOIA, Government, Defense Finance and Accounting Service, Multimedia, American Institute of Certified Public Accountants, Inactive, Acquisition, Organization, Management, Online shopping, Kannan, Service, Merck, Washington Metro

GAITHERSBURG, Md., Dec. 5, 2022 /PRNewswire/ -- AINS, LLC, the leading provider of low-code, adaptive case management software for government, named Patrick Kannan as its new Chief Financial Officer. He has built a professional career in Finance and Accounting with companies offering Software as a Service (SaaS) solutions, coupled with professional services, enabling structured or unstructured secure collaboration for BAE Systems, The Boeing Company, Lockheed Martin, Raytheon Technologies, Rolls-Royce and Merck.

Key Points: 
  • GAITHERSBURG, Md., Dec. 5, 2022 /PRNewswire/ -- AINS, LLC , the leading provider of low-code, adaptive case management software for government, named Patrick Kannan as its new Chief Financial Officer.
  • AINS CEO Howard Langsam said, "Patrick Kannan brings decades of experience and will be a tremendous asset as our new CFO.
  • Most recently, Kannan was CFO at Exostar where he spent more than a decade leading financial teams and driving growth for the business resulting in a successful acquisition by private equity company Thoma Bravo in 2020.
  • Kannan said, "When I was looking for my next opportunity, two things stood out to me about AINS: its culture and alignment.

The End of the Alphabet, The Beginning of a New Era: OpenStack Zed Release Arrives as OpenStack Deployments Surge Beyond 40M Cores

Retrieved on: 
Wednesday, October 5, 2022
Nova, OpenStack, BBC Research & Development, DataCore, A100, MIG, Internet Technical Committee, Calling Name Presentation, Linux, Xilinx, NVIDIA, Pure Storage, Organization, Architecture, European Centre for Medium-Range Weather Forecasts, Blizzard Entertainment, Gracemont (microarchitecture), PGPU, Index, Vancouver Convention Centre, FC, VGPU, History, Technology, VMS, Software, Graphics processing unit, AI, ISCSI, Research, UI, GPU, Running, Inactive, Dell, PTG, Solution, Online shopping, Cryptocurrency, Logging, Zed, TensorFlow, Cyborg

AUSTIN, Texas, Oct. 4, 2022 /PRNewswire-PRWeb/ -- The OpenStack community today released Zed, the 26th version of the world's most widely deployed open source cloud infrastructure software. Zed highlights include enhanced security features and expanded hardware enablement. In addition, the OpenStack community is responding to user feedback through two new projects, Venus, which delivers log aggregation for large deployments, and Skyline, which promises an improved web UI.

Key Points: 
  • All this has happened against a backdrop of consistent usability improvements, enabling deployments sizes that range from a few dozen to millions of cores.
  • "We're 12 years in, and OpenStack deployments continue to grow at an incredible pace: just a year ago we celebrated 25 million cores, and we're already exceeding 40 million cores in production today.
  • Feature advancements in Zed include:
    Cinder: Block Storage API microversion 3.70 adds the ability for users to transfer encrypted volumes across projects.
  • New Release Cadence: OpenStack 2023.1 Antelope is the first Skip Level Upgrade Release Process (SLURP) release in a new release cadence established by the Technical Committee.

Demotech Announces Additional Faculty for Its Wrap-Up on Legislative Special Session on Florida Property Insurance

Retrieved on: 
Friday, May 13, 2022
CPA, MBA, Crime, Commissioner, Inactive, Emmy Awards, Multimedia, ACAS, Review, Grade (consulting), WFLA, Esquire, Industry, Assistant District Secretary of Chama Cha Mapinduzi, Faculty, Goldman Sachs, CPCU, ASA, CFA, MAAA, Insurance, Title

COLUMBUS, Ohio, May 13, 2022 /PRNewswire/ --Demotech, Inc., the first to request a special session to address the litigation crisis affecting Florida's residential property insurance marketplace, announces additional faculty for its June 2 webinar.

Key Points: 
  • COLUMBUS, Ohio, May 13, 2022 /PRNewswire/ --Demotech, Inc., the first to request a special session to address the litigation crisis affecting Florida's residential property insurance marketplace, announces additional faculty for its June 2 webinar.
  • Scheduled from 1100 am to 1230 Eastern, the webinar provides these experts with a forum to share their opinions of the initial outcome of the special session.
  • More recently, we were the first to call for a special session on Florida's property insurance marketplace.
  • Since 1985, Demotech has served the industry by assigning accurate, reliable, and proven Financial Stability Ratings to Property & Casualty insurers and Title underwriters.

Vasculitis Pipeline Insights Report 2022: Comprehensive Insights about 40+ Companies and 40+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 21, 2022
Health, Pharmaceutical, Giant, Amputation, NDA, GCA, News, C5a, Giant cell arteritis, Clinical trial, Axial spondyloarthritis, Antidepressant discontinuation syndrome, ANCA, B-cell activating factor, Research, Psoriasis, Giant cell, Novartis, Route of administration, E-selectin, Route, Inflammation, Time-invariant system, III, Psoriatic arthritis, Inactive, AAV, Technology, Discovery, Secukinumab, Blood, ROA, Belimumab, Administration, Acquisition, Vascular disease, Regeneration, Survival, Medical device, Pharmaceutical industry, Vaccine, Vasculitis

The "Vasculitis - Pipeline Insight, 2022" report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Vasculitis pipeline landscape.

Key Points: 
  • The "Vasculitis - Pipeline Insight, 2022" report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Vasculitis pipeline landscape.
  • The assessment part of the report embraces, in depth Vasculitis commercial assessment and clinical assessment of the pipeline products under development.
  • Companies and academics are working to assess challenges and seek opportunities that could influence Vasculitis R&D.
  • Vasculitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Palmar Hyperhidrosis Pipeline Market Insights Report 2022 Featuring Key Players - Atacama Therapeutics, GlaxoSmithKline, Brickell Biotech, & Candesant Biomedical - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 21, 2022
Health, Pharmaceutical, NDA, News, Hyperhidrosis, Clinical trial, Antidepressant discontinuation syndrome, Umeclidinium bromide, Route of administration, Therapy, Route, II, GlaxoSmithKline, Inactive, Technology, Discovery, ROA, Administration, Acquisition, Mecamylamine, Muscarinic acetylcholine receptor, Pharmaceutical industry

The "Palmar Hyperhidrosis - Pipeline Insight, 2022" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Palmar Hyperhidrosis pipeline landscape.

Key Points: 
  • The "Palmar Hyperhidrosis - Pipeline Insight, 2022" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Palmar Hyperhidrosis pipeline landscape.
  • A detailed picture of the Palmar Hyperhidrosis pipeline landscape is provided which includes the disease overview and Palmar Hyperhidrosis treatment guidelines.
  • The assessment part of the report embraces in depth Palmar Hyperhidrosis commercial assessment and clinical assessment of the pipeline products under development.
  • Palmar Hyperhidrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Saniona appoints Robert Hoffman to Board of Directors as Chair of the Audit Committee

Retrieved on: 
Thursday, September 16, 2021
St. Bonaventure University, KTRA, Arena, Database, Drug discovery, Weight gain, FASB, IPO, BBA, Heron, Patient, Inactive, Antibe Therapeutics, Pain, CFO, List of life sciences, Nasdaq, Fundraising, Hunger, Degenerative disease, Financial Accounting Standards Board, CPA, Association, Therapy, Tomorrow Could Be the Day Things Change, Strategic planning, Prader–Willi syndrome, ASLN, OMX, Arena Pharmaceuticals, Organization, Accounting, TSX, Disorder, Leadership, Management, Pharmaceutical industry

Hoffman is an experienced financial executive and board member with nearly 30 years of experience and achievements in accounting, finance, fund raising, strategic planning, corporate governance, investor relations, and leadership.

Key Points: 
  • Hoffman is an experienced financial executive and board member with nearly 30 years of experience and achievements in accounting, finance, fund raising, strategic planning, corporate governance, investor relations, and leadership.
  • I see in Saniona a company with a considerable amount of untapped potential.
  • Hoffman also serves as a board member of the Association of Bioscience Financial Officers and FibroBiologics, Inc., a private biotechnology company.
  • As a founder of Day For Change, a not-for-profit that serves underprivileged and abused children in San Diego, Hoffman has served on its board of directors for 20 years.